A characterization of anxiolytic-like actions induced by the novel NMDA/glycine site antagonist, L-701,324

Psychopharmacology

Volumn 135, Issue 2, 1998, Pages 175-181

  Kotlinska, Jolanta ^a   Liljequist, Sture ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Antianxiety agents; Diazepam; L 701,324; NMDA glycine receptor antagonist; Plus maze; RAT; Vogel's conflict test

Indexed keywords

7 CHLORO 4 HYDROXY 3 (3 PHENOXYPHENYL) 2 QUINOLONE; DIAZEPAM; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DRINKING BEHAVIOR; INTRAVENOUS DRUG ADMINISTRATION; LOCOMOTION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; DIAZEPAM; EXCITATORY AMINO ACID ANTAGONISTS; MALE; MOTOR ACTIVITY; QUINOLONES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, GLYCINE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 0031974244     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050499     Document Type: Article

References (45)

1. Bristow LJ, Flatman KL, Hutson PH, Kulagowski JL, Leeson PD, Young L, Tricklebank MD (1996a) The atypical neuroleptic profile of the glycine/N-methyl-D-aspartate antagonist, L-710,324, in rodents. J Pharmacol Exp Ther 277:578-585
2. Bristow LJ, Hutson PH, Kulagowski JJ, Leeson J, Matheson S, Murray F, Rathbone D, Saywell KL, Thorn L, Watt AP, Tricklebank MD (1996b) The anticonvulsant and behavioural profile of L-701, 324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate (NMDA) receptor complex. J Pharmacol Exp Ther 279: 429-501
3. Corbett R, Dunn RW (1991) Effects of HA-966 on conflict, social interaction, and plus maze behaviors. Drug Dev Res 24: 201-205
4. Corbett R, Dunn RW (1993) Effects of 5,7 dichlorokynurenic acid on conflict, social interaction and plus maze behaviors. Neuropharmacology 32:461-466
5. Fagg GE (1987) Phencyclidine and related drugs bind to the activated N-methyl-D-aspartate receptor-channel complex in rat brain membranes. Neurosci Lett 76:221-227
6. Fix AS, Horn JW, Wightman KA, Johnson CA, Long GG, Storts RW, Farber N, Wozniak DF, Olney JW (1993) Neuronal vacuolization and necrosis induced by the noncompetitive N-methyl-D-aspartate (NMDA) antagonist MK(+)-801 (dizocilpine maleate): a light and electron microscopic evaluation of the rat retrosplenial cortex. Exp Neurol 123:204-215
7. Fraser CM, Cooke MJ, Fisher A, Thompson ID, Stone TW (1996) Interactions between ifenprodil and dizocilpine on mouse behaviour in models of anxiety and working memory. Eur Neuropsychopharmocol 6:311-316
8. Gill R, Hargreaves RJ, Kemp JA (1995) The neuroprotective effect of the glycine site antagonist 3R-(+)-cis-4-methyl-HA966 (L-687, 414) in a rat model of focal ischemia. J Cereb Blood Flow Metab 15:197-204
9. Grimwood S, Kulagowski JJ, Mawer IM, Rowley M, Leeson PD, Foster AC (1995) Allosteric modulation of the glutamate site on the NMDA receptor by four novel glycine site antagonists. Eur J Pharmacol [Mol Pharmacol Sect] 290:221-226
10. Grotta J, Clark W, Coull B, Peltigrew LC, Mackay B, Goldstein LB, Meissner I, Murphy D, LaRue L (1995) Safety and tolerability of the glutamate antagonist CGS 19755 (Selfotel) in patients with acute ischemic stroke. Results of a phase IIa randomized trial. Stroke 26:602-605
11. Hargreaves RJ, Rigby M, Smith D, Hill RG (1993) Lack of effect of L-687, 414 [(+)-cis-4-methyl-HA-966], an NMDA receptor antagonist acting at the glycine site, on cerebral glucose metabolism and cortical neuronal morphology. Br J Pharmacol 110: 36-42
12. Hawkinson JE, Huber KR, Sahota PS, Hsu HH, Weber E, Whitehouse MJ (1997) The N-methyl-D-aspartate (NMDA) receptor glycine site antagonist ACEA 1021 does not produce pathological changes in rat brain. Brain Res 744:227-234
13. Hollman M, Heinemann S (1944) Cloned glutamate receptors. Annu Rev Neurosci 17:31-108
14. Huber K, Sahota P, Kapeghian J, Hau Hsu H, Amemiya K, Arthur A, Tripp S, Traina V (1997) Lack of neuronal vacuolization and necrosis in monkeys treated with Selfotel (CGS 19755), a competitive N-methyl-D-aspartate (NMDA) receptor antagonist. J Am Coll Toxicol 16:1
15. Hutson PH, Bristow LJ, Thorn L, Tricklebank MD (1995) L-701,324, a glycine/NMDA receptor antagonist, attenuates activation of the mesolimbic dopamine system by phencyclidine. Br J Pharmacol 114:322P
16. Ilyin VI, Whittemore ER, Tran M, Shen K-Z, Cai S-X, Kher SM, Keana JFW, Weber E, Woodward RM (1966) Pharmacology of ACEA-1416: a potent systemically active NMDA receptor glycine antagonist. Eur J Pharmacol 310:107-114
17. Jessa M, Nazar M, Bidzinski A, Plaznik A (1996) The effects of repeated administration of diazepam, Mk-801 and CGP 37489 on rat behavior in two models of anxiety. Eur Neuropsychopharmocol 6:55-61
18. Karcz-Kubicha M, Liljequist S (1995) Evidence for an anxiogenic action of AMPA receptor antagonists in the plus-maze test. Eur J Pharmacol 279:171-177
19. Keana JFW, Kher SM, Cai SX, Dinsmore CM, Glenn AG, Guastella J, Huang J-C, Ilyin V, Lü Y, Mouser PL, Woodward RM, Weber E (1995) Synthesis and structure-activity relationships of substituted 1,4-dihydroquinoxaline-2,3-diones: antagonists of the N-methyl-D-aspartate (NMDA) receptor glycine sites and non-NMDA glutamate receptors. J Med Chem 38:4367-4379
20. Kehne JH, McCloskey TC, Baron BM, Chi EM, Harrison BL, Whitlen JP, Palfreyman MG (1991) NMDA receptor complex antagonists have potential anxiolytic effects as measured with separation-induced ultrasonic vocalizations. Eur J Pharmacol 193:283-292
21. Kehne JH, Baron BM, Harrison BL, McCloskey TC, Palfreyman MG, Poirot M, Salituro FG, Siegel BW, Slone AL, Van Giersbergen PLM, White HS (1995) MDL 100, 458 and MDL 102, 228: two potent and selective glycine receptor antagonists with different functional profiles. Eur J Pharmacol 248:109-118
22. Kotlinska J, Liljequist S (1996) Oral administration of glycine and polyamine receptor antagonists blocks ethanol withdrawal seizures. Psychopharmacology 127:238-244
23. Kotlinska J, Liljequist S (1997) The NMDA/glycine receptor antagonist, L-701,324, produces discriminative stimuli similar to those of ethanol. Eur J Pharmacol 332: 1-8
24. Leeson PD, Iversen LL (1994) The glycine site on the NMDA receptor: structure-activity relationships and therapeutic potential. J Med Chem 37:4053-4067
25. Liljequist S (1991) Genetic differences in the effects of competitive and non-competitive NMDA receptor antagonists on locomotor activity in mice. Psychopharmacology 104:17-21
26. Liljequist S, Engel JA (1984) The effects of GABA and benzodiazepine antagonists on the anticonflict actions of diazepam and ethanol. Pharmacol Biochem Behav 21:521-525
27. Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180-185
28. Möller C, Wiklund L, Sommer W, Thorsell A, Heilig M (1997) Decreased experimental anxiety and voluntary ethanol consumption in rats following central but not basolateral amygdala lesions. Brain Res 760:94-101
29. Mori H, Mishina M (1995) Structure and function of the NMDA receptor channel. Neuropharmacology 10:1219-1237
30. Nagata R, Tanno N, Kodo T, Ae N, Yamaguchi H, Nishimura T, Antoku F, Tatsuno T, Kato T, Tanaka Y, Nakamura M (1994) Tricyclic quinoxalinediones: 5,6-dihydro-1H-pyrrolo[1,2,3-de] quinoxaline-2,3-diones and 6,7-dihydro-1H,5H-pyrido[1,2,3-de]quinoxaline-2,3-diones as potent antagonists for the glycine binding site of the NMDA receptor. J Med Chem 37:3956-3968
31. Obrenovitch TP, Zilkha E (1996) Inhibition of cortical spreading depression by L-701,324, a novel antagonist at the glycine site of the N-methyl-D-aspartate receptor complex. Br J Pharmacol 117:931-937
32. Pellow S, File S (1986) Anxiolytic and anxiogenic drug effects on exploratory activity in the elevated plus-maze: a novel test of anxiety in rat. Pharmacol Biochem Behav 24:525-529
33. Plaznik A, Palejko W, Nazar M, Jessa M (1994) Effects of antagonists at the NMDA receptor complex in two models of anxiety. Eur Neuropsychopharmacol 4:503-512
34. Priestley T, Laughton P, Macaulay AJ, Hill RG, Kemp JA (1996) Electrophysiological characterisation of the antagonist properties of two novel NMDA receptor glycine site antagonists, L-695,902 and L-701,324. Neuropharmacology 35:1573-1581
35. Rogawski M (1996) Excitatory amino acids and seizures. In: Stone TW (ed) CNS Neurotransmitters and neuromodulators: glutamate. CRC Press, London, pp 219-238
36. Rupniak NMJ, Boyce S, Tye S, Cook G, Iversen SD (1993) Anxiolytic-like and antinociceptive effects of MK-801 accompanied by sedation and ataxia in primates. Pharmacol Biochem Behav 44:153-156
37. Sharma AC, Kulkarni SK (1991) MK-801 produces antianxiety effect in elevated plus-maze in mice. Drug Dev Res 22: 251-258
38. Tricklebank MD, Singh L, Oles RJ, Preston C, Iversen SD (1989) The behavioural effects of MK-801: a comparison with antagonists acting non-competitively at the NMDA receptor. Eur J Pharmacol 167:127-135
39. Trullas R, Jackson B, Skolnick P (1989) Anxiolytic properties of 1-aminocyclopropane-carboxylic acid, a ligand at strychnine-insensitive glycine receptors. Pharmacol Biochem Behav 34:313-316
40. Tsuchida E, Bullock R (1995) The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA-1021 on ischemic brain damage caused by acute subdural hematoma in the rat. J Neurotrauma 12:279-288
41. Warner DS, Martin H, Ludwig P, McAllister A, Keana JFW, Weber E (1995) In vivo models of cerebral ischemia: effects of parenterally administered NMDA receptor glycine site antagonists. J Cereb Blood Flow Metab 15:188-196
42. Wiley JL, Cristello AF, Balster RL (1995) Effects of site-selective NMDA receptor antagonists in an elevated plus-maze model of anxiety in mice. Eur J Pharmacol 294:101-107
43. Witkin JM (1996) Role of NMDA receptors in behavior and behavioral effects of drugs. In: Stone TW (ed) CNS neurotransmitters and neuromodulators: glutamate. CRC Press, London, pp 323-350
44. Woodward RM, Huettner JE, Guastella J, Keana JFW, Weber E (1995) In vitro pharmacology of ACEA-1021 and ACEA-1031: systemically active quinoxalinediones with high affinity and selectivity for N-methyl-D-aspartate receptor glycine sites. Mol Pharmacol 47:568-581
45. Xie Z, Commissaris RL (1992) Anxiolytic-like effects of the non-competitive NMDA antagonist MK-801. Pharmacol Biochem Behav 43:471-477